Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV midazolam infusion vs IV sodium valproate for pediatric status epilepticus
TCTR20231115003Phase 3Unknown
- Sponsor
- University of Health Sciences Lahore
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam and valproic acid in status epilepticus (SE) (2 arms), sponsored by University of Health Sciences Lahore. Status: unknown.
02
Drugs
midazolamvalproic acid
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on TCTR20231115003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231115003.